ATP and cancer immunosurveillance

EMBO J. 2021 Jul 1;40(13):e108130. doi: 10.15252/embj.2021108130. Epub 2021 Jun 14.

Abstract

While intracellular adenosine triphosphate (ATP) occupies a key position in the bioenergetic metabolism of all the cellular compartments that form the tumor microenvironment (TME), extracellular ATP operates as a potent signal transducer. The net effects of purinergic signaling on the biology of the TME depend not only on the specific receptors and cell types involved, but also on the activation status of cis- and trans-regulatory circuitries. As an additional layer of complexity, extracellular ATP is rapidly catabolized by ectonucleotidases, culminating in the accumulation of metabolites that mediate distinct biological effects. Here, we discuss the molecular and cellular mechanisms through which ATP and its degradation products influence cancer immunosurveillance, with a focus on therapeutically targetable circuitries.

Keywords: ADORA2A; CD39; CD73; autophagy; immune checkpoint inhibitors; immunogenic cell death.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Adenosine Triphosphate / immunology*
  • Adenosine Triphosphate / metabolism*
  • Animals
  • Humans
  • Neoplasms / immunology*
  • Neoplasms / metabolism*
  • Signal Transduction / immunology
  • Tumor Microenvironment / immunology
  • Tumor Microenvironment / physiology

Substances

  • Adenosine Triphosphate